← Back to Search

Intervention for Human Papillomavirus (RACE Trial)

N/A
Waitlist Available
Led By Radhika Gogoi, M.D. PhD
Research Sponsored by Radhika Gogoi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

The goal of this clinical trial is to assess the feasibility of using interactive teaching to educate cervical cancer patients about Human papillomavirus (HPV) and HPV vaccinations.

Eligible Conditions
  • Cervical Cancer
  • Human Papillomavirus
  • Vaginal Cancer
  • Vulvar Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Participation Rate
Survey Completion Rate
Secondary study objectives
Change in Health Literacy
Change in Stigma
Change in intention to discuss HPV vaccination
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention group will be shown an educational video
Group II: ControlActive Control1 Intervention
The control group will be given a standardized handout

Find a Location

Who is running the clinical trial?

Radhika GogoiLead Sponsor
University of OklahomaOTHER
472 Previous Clinical Trials
93,552 Total Patients Enrolled
Radhika Gogoi, M.D. PhDPrincipal InvestigatorKarmanos Cancer Center
~19 spots leftby Nov 2025